ATNX - Athenex Inc
Close
0.2031
-0.062 -30.527%
Share volume: 0
Last Updated: Wed 24 May 2023 10:00:00 PM CEST
Pharmaceutical Preparation Manufacturing :
-2.88%
PREVIOUS CLOSE
CHG
CHG%
$0.27
-0.06
-23.39%
View ratios
Fiscal Date | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | |
---|---|---|---|---|---|
Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | |
Report Date | 2022-05-10 | 2022-07-29 | 2022-11-03 | 2023-03-20 | |
Assets | |||||
Total Assets | 236.862 M | 221.887 M | 228.350 M | 204.055 M | |
Current Assets | 131.588 M | 117.746 M | 126.706 M | 124.929 M | |
Inventories | 41.253 M | 37.851 M | 42.039 M | 42.654 M | |
Other Current Assets | 9.521 M | 3.975 M | 4.125 M | 10.578 M | |
Short Term Investments | 9.521 M | 3.975 M | 4.125 M | 10.578 M | |
Total Receivables | 29.605 M | 33.824 M | 32.912 M | 27.865 M | |
Current Cash | 37.459 M | 23.328 M | 36.221 M | 31.508 M | |
Total Non-current Assets | 105.274 M | 104.141 M | 101.644 M | 79.126 M | |
Property Plant Equipment | 26.863 M | 4.194 M | 3.912 M | 1.824 M | |
Other Assets | 1.048 M | 991.000 K | 952.000 K | 804.000 K | |
Intangible Assets | 71.567 M | 72.472 M | 72.168 M | 72.112 M | |
Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | |
Liabilities and shareholders’ equity | |||||
Total Liabilities and shareholders’ equity | 236.862 M | 221.887 M | 228.350 M | 204.055 M | |
Total liabilities | 198.872 M | 209.952 M | 203.505 M | 210.561 M | |
Total current liabilities | 80.784 M | 90.171 M | 84.903 M | 114.879 M | |
Accounts Payable | 16.605 M | 21.397 M | 25.071 M | 33.682 M | |
Other liabilities | 27.014 M | 101.824 M | 101.749 M | 108.462 M | |
Current long term debt | 24.680 M | 23.738 M | 14.927 M | 37.127 M | |
Long term debt | 102.231 M | 22.226 M | 22.251 M | 93.000 K | |
Other liabilities | 27.014 M | 101.824 M | 101.749 M | 108.462 M | |
Minority interest | -17.191 M | -17.408 M | -17.609 M | -17.675 M | |
Total Shareholder equity | 37.990 M | 11.935 M | 24.845 M | -6.506 M | |
Common stock | 110.504 M | 113.006 M | 139.473 M | 8.015 M | |
Retained earnings | -930.832 M | -962.989 M | -982.658 M | -1.017 B |